150 likes | 322 Views
EMCDDA. KEY INDICATOR: Treatment demand. Objective of indicator. To provide comparable, reliable and anonymous information on the number and characteristics of people treated for their drug use in the Member States. Purpose of information. Indirect indicator of trends in problem drug use
E N D
EMCDDA KEY INDICATOR: Treatment demand
Objective of indicator • To provide comparable, reliable and anonymous information on the number and characteristics of people treated for their drug use in the Member States.
Purpose of information Indirect indicator of trends in problemdrug use Identification of patterns of drug use Basis for other methodologies on problem drug use prevalence estimation; Identify patterns of use of services and plan and evaluation of services
Policy relevance • · Monitor trends in prevalence and characteristics of users • ·Plan and asses resources, and evaluate service uptake by users ·service management, ·outcome evaluation –EU action Plan
How to implement the indicator: Guidelines A joint EMCDDA/Pompidou Group protocol (TDI protocol), given definitions and guidelines for data collection
Guidelines * What is drug treatment ? • * Which substances are notified • * When treatment starts and finish (treatment episode) - * Time and area of reporting - * How many times a person should be counted in the time and area covered (control of double counting) * Variables to be collected per case
Instruments for data collection • -National Reitox Reports (simplified standard tables) - TDI tables (detailed tables)
Process of guidelines development (1996 to 2001) Ø Identification and in-depth analysis of existing national reporting systems ØIdentification and in-depth analysis of existing national reporting systems ØDevelopment of working agreed standards (use of Pompidou Group protocol as reference) ØAssessment of feasibility …
Guidelines development processIn cooperation with the Pompidou (Council of Europe) AND… Ø Extensive field-testing Ø Final protocol ØAdoption by Scientific Committee (Dec 2000) and Management Board of EMCDDA (2001)
Some problems encountered Ø Differences in services provision and organisation Ø Differences in methodological approach to treatment information in some countries Ø Differences in geographical and services coverage between countries ØModifications of national reporting systems are costly and require institutional commitment
Work process with treatment demand information Methodology development · Definitions – concepts –> TDI protocol · Technical instruments · Institutional agreements · Field-testing ·Data collection and databases development
…And quality assessment · Coverage analysis · Validity and reliability
Steps for using treatment demand information To identify topics and questions ØRelevance of problems (policy needs; cocaine, cannabis…) ØAppropriateness of treatment information ØFeasibility with data collected
Starting point ØEMCDDA initiative:individually, with groups of experts, with other organisations ØFormal demands:Annual Report, EU Action Plan on drugs ØInitiatives from other indicators: New trends, infectious diseases
Different levels of analysis 1- National : cross national (all EU countries, selection of countries) ; 2- Aggregated: individual data (centrally vs national level with common protocol)